'Sometimes I get goosebumps,' says Bharat Biotech MD as firm preparing for Covaxin rollout

- Bharat Biotech has already produced about 10 million doses of its Covaxin shot
- Bharat has spent about $60 million to $70 million so far developing coronavirus vaccines